| Stereochemistry | ABSOLUTE |
| Molecular Formula | C19H23NO3.ClH |
| Molecular Weight | 349.852 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC=CC(=C1)C(=O)CCN[C@@H](C)[C@H](O)C2=CC=CC=C2
InChI
InChIKey=JMUPNNYLJGSMPK-JPJJPTBZSA-N
InChI=1S/C19H23NO3.ClH/c1-14(19(22)15-7-4-3-5-8-15)20-12-11-18(21)16-9-6-10-17(13-16)23-2;/h3-10,13-14,19-20,22H,11-12H2,1-2H3;1H/t14-,19-;/m0./s1
Originator
Approval Year
Doses
AEs
PubMed
Patents
Sample Use Guides
Oral
Myocardial infarction, Angina pectoris
Adult: 8-24 mg tid.
Route of Administration:
Oral
Oxyfedrine was tested in vitro against 471 strains of bacteria from two Gram positive and fourteen Gram negative genera. The minimum inhibitory concentration (MIC) of oxyfedrine was determined by agar dilution method, which ranged from 50-200 ug/ml in most of the strains, while some strains were inhibited at even lower concentrations.
ACTIVE MOIETY
SUBSTANCE RECORD
